Inventor
MORTON HOWARD E
US29 patents
⚠️ This page may combine multiple inventors who share the name “MORTON HOWARD E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
20 patentsUS6437106B1Aug 20, 2002
Process for preparing 6-o-substituted erythromycin derivatives
ABBOTT LAB161 citations96
US5491253AFeb 13, 1996
Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB25 citations94
US5654466AAug 5, 1997
Process for the preparation of a disubstituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB9 citations82
US5616776AApr 1, 1997
Process for the preparation of a substituted 2.5-diamono-3-hydroxy-hexane
ABBOTT LAB14 citations81
US5712400AJan 27, 1998
Process for preparation of 5-hydroxymethylthiazole
ABBOTT LAB8 citations73
US5210206AMay 11, 1993
1,3-oxazolyl substituted biphenyl
ABBOTT LAB15 citations73
US5275950AJan 4, 1994
Process for the preparation of a renin inhibiting compound
ABBOTT LAB8 citations72
US5565604AOct 15, 1996
Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB2 citations62
US5229518AJul 20, 1993
Isomerically pure 2-piperidone compounds
ABBOTT LAB4 citations62
US6710185B2Mar 23, 2004
Process for the preparation of cell proliferation inhibitors
ABBOTT LAB2 citations61
US5543551AAug 6, 1996
Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane
ABBOTT LAB2 citations61
US6518430B1Feb 11, 2003
Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
ABBOTT LAB2 citations59
US5625092AApr 29, 1997
Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane
ABBOTT LAB0 citations52
US5543549AAug 6, 1996
Process for the preparation of a substituted 2,5-Diamino-3-Hydroxyhexane
ABBOTT LAB0 citations52
US5569777AOct 29, 1996
Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB0 citations51
US5543552AAug 6, 1996
Process for the prepartation of a substituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB0 citations51
US5541328AJul 30, 1996
Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
ABBOTT LAB0 citations51
US5342981AAug 30, 1994
Substantially isomerically pure hexane or hexene compounds
ABBOTT LAB0 citations51
US6608216B2Aug 19, 2003
Process for the preparation of chiral glucocorticoid receptor agents
ABBOTT LAB0 citations40
US6605707B1Aug 12, 2003
Process for the preparation of 6-O-propargyl erythromycin derivatives
ABBOTT LAB0 citations35
MERCK FROSST CANADA INC
6 patentsUS5081138AJan 14, 1992
3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith
MERCK FROSST CANADA INC73 citations96
US5225421AJul 6, 1993
3-hetero-substituted-N-benzyl-indoles and medical methods of use therefor
MERCK FROSST CANADA INC21 citations92
US5017597AMay 21, 1991
Cyclohept(B)indolealkanoic acids, pharmaceutical compositions and use
MERCK FROSST CANADA INC6 citations63
US4906654AMar 6, 1990
Cyclohept[b]indoleakanoic acids, pharmaceutical compositions and use
MERCK FROSST CANADA INC2 citations63
US4611068ASep 9, 1986
Process for the preparation of HMG-CoA reductase inhibitors and intermediate compounds employed therein
MERCK FROSST CANADA INC6 citations63
US5017593AMay 21, 1991
Cyclohept[b]indolealkanoic acids, pharmaceutical compositions and use
MERCK FROSST CANADA INC0 citations42